You searched for "diagnostic"
Understanding vasoproliferative retinal tumours
Syed Irtiza Ali Shah explores this rare and unusual condition through a fascinating case presentation. Vasoproliferative tumours of the retina (VPTR) are a vascular mass with an associated exudative retinopathy alongside the presence of minimally dilated feeder vessels. This is...New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.Standby for standards: Ophthalmic imaging
The Ophthalmic Imaging Associating (OIA) will propose and publish a volume of refined standards for Ophthalmic and Vision Science. These will be reviewed by the OIA membership at its annual conference in November 2025 and released thereafter. The OIA is...Newmedica welcomes GIRFT glaucoma guidance but calls for equitable commissioning to protect patient access
Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...Leicester Community Eye Hospital recognised as ‘Good’
Care and Quality Commission awards CHEC coveted quality rating.PREVIEW: International SPECTRALIS Symposium – AND BEYOND
The International SPECTRALIS Symposium (ISS) marks its 21st anniversary with an exciting new chapter in Heidelberg, Germany, just steps away from the headquarters of Heidelberg Engineering. Recognised as one of the most prestigious scientific imaging conferences, ISS 2025 will bring...International SPECTRALIS Symposium – AND BEYOND
Hemel Hempstead, Hertfordshire. UK (11 March 2025) - The International SPECTRALIS Symposium (ISS) celebrates 21 Years of Innovation in Ophthalmic Imaging at the New Heidelberg Congress Center, 13–14 June 2025, just steps away from the headquarters of Heidelberg Engineering. Recognized...TowardPi Brings Next-Generation OCT/A to the UK
TowardPi, a fast-growing leader in ophthalmic imaging, has entered the UK market with its advanced swept-source OCT (SS-OCT) and OCT angiography (OCTA) systems. Distributed exclusively by Mainline Instruments, TowardPi is already well-established in Asia and is recognised for pioneering the...Heidelberg Engineering joins the Collaborative Community on Ophthalmic Innovation (CCOI) through EssilorLuxottica’s Vision Architect membership
Heidelberg Engineering announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica’s Vision Architect membership – CCOI’s highest level of industry participation. CCOI is a public–private forum that convenes patients, clinicians,...Inherited retinal disorders now the leading cause of blindness
The recent paper in BMJ Open, from the UCL Institute of Ophthalmology, ‘A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010’ concludes that inherited retinal disorders (IRD) such...
Neurofibromatosis type 1 features
The aim in this study was to identify the incidence and de nova mutation rate of Neurofibramatosis type 1 (NF1) and describe the ocular and non-ocular findings in a population-based cohort of patients diagnosed over a 30-year period. The study...
